Search research articles
Contact Us
Filters
Showing results (91-100 of 1,043) with videos related to
Page
of 105
Sort By:
Journal of the American Geriatrics Society
|
January 19, 2024
Targeting cardiac and cerebrovascular risks of sarcopenia: Is it time to screen for muscle health?
Saeid Mirzai, W H Wilson Tang
JACC. Basic to Translational Science
|
January 23, 2023
Keeping the Failing Heart in Check: Can Modulating Immune Checkpoints Promote Myocardial Recovery?
Weili Zheng, W H Wilson Tang
Current Treatment Options in Cardiovascular Medicine
|
July 12, 2024
Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction
Nandan Kodur, W H Wilson Tang
Cleveland Clinic Journal of Medicine
|
December 24, 2015
Biomarkers: Their potential in the diagnosis and treatment of heart failure
Barbara Heil, W H Wilson Tang
Revista Espanola De Cardiologia (English Ed.)
|
July 13, 2016
What Should We Target in Heart Failure: Hemoglobin or Iron?
Nael Hawwa, W H Wilson Tang
Journal of Cardiac Failure
|
October 6, 2015
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Yuji Nagatomo, W H Wilson Tang
Revista Espanola De Cardiologia (English Ed.)
|
May 23, 2017
The Role and Impact of Gut Microbiota in Cardiovascular Disease
Takeshi Kitai, W H Wilson Tang
Current Heart Failure Reports
|
June 30, 2017
Therapeutic Strategies Targeting Inherited Cardiomyopathies
Kenneth Varian, W H Wilson Tang
JACC. Basic to Translational Science
|
November 13, 2024
Targeting Mitochondria Dysfunction in LMNA Cardiomyopathy
Chia-Feng Liu, W H Wilson Tang
European Journal of Heart Failure
|
April 28, 2016
Endothelin-1 is independently associated with 180-day mortality after adjusting for body mass index
Antonio L Perez, W H Wilson Tang
Page
of 105
Search research articles
Search
Showing results (91-100 of 1,043) with videos related to
Sort By:
Page
of 105
Journal of the American Geriatrics Society
|
January 19, 2024
Targeting cardiac and cerebrovascular risks of sarcopenia: Is it time to screen for muscle health?
Saeid Mirzai, W H Wilson Tang
JACC. Basic to Translational Science
|
January 23, 2023
Keeping the Failing Heart in Check: Can Modulating Immune Checkpoints Promote Myocardial Recovery?
Weili Zheng, W H Wilson Tang
Current Treatment Options in Cardiovascular Medicine
|
July 12, 2024
Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction
Nandan Kodur, W H Wilson Tang
Cleveland Clinic Journal of Medicine
|
December 24, 2015
Biomarkers: Their potential in the diagnosis and treatment of heart failure
Barbara Heil, W H Wilson Tang
Revista Espanola De Cardiologia (English Ed.)
|
July 13, 2016
What Should We Target in Heart Failure: Hemoglobin or Iron?
Nael Hawwa, W H Wilson Tang
Journal of Cardiac Failure
|
October 6, 2015
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Yuji Nagatomo, W H Wilson Tang
Revista Espanola De Cardiologia (English Ed.)
|
May 23, 2017
The Role and Impact of Gut Microbiota in Cardiovascular Disease
Takeshi Kitai, W H Wilson Tang
Current Heart Failure Reports
|
June 30, 2017
Therapeutic Strategies Targeting Inherited Cardiomyopathies
Kenneth Varian, W H Wilson Tang
JACC. Basic to Translational Science
|
November 13, 2024
Targeting Mitochondria Dysfunction in LMNA Cardiomyopathy
Chia-Feng Liu, W H Wilson Tang
European Journal of Heart Failure
|
April 28, 2016
Endothelin-1 is independently associated with 180-day mortality after adjusting for body mass index
Antonio L Perez, W H Wilson Tang
Page
of 105